Skip to content

BBNX BBNX Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$14.74M-7.6%
Insulet logo
InsuletPODD

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's change in accrued liabilities?
BBNX (BBNX) reported change in accrued liabilities of -$5.22M in Q1 2026.
How has BBNX's change in accrued liabilities changed year-over-year?
BBNX's change in accrued liabilities increased by 1.1% year-over-year, from -$5.27M to -$5.22M.
What is the long-term trend for BBNX's change in accrued liabilities?
Over 2 years (2023 to 2025), BBNX's change in accrued liabilities has grown at a 101.7% compound annual growth rate (CAGR), from $1.83M to $7.42M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.